GLP-1 receptor agonists
5 statements across 2 episodes · 4 bullish · 0 bearish · 1 people on the record · first statement Feb 7, 2025 by David Friedberg · across every show →
Everything said about GLP-1 receptor agonists, oldest first
Feb 7, 2025 neutral
Feb 7, 2025 positive
Feb 10, 2025 positive
Friedberg: GLP-1 drugs provide health benefits independent of weight loss
“So we know that the GLP-I receptor agonist means that it binds to these GLP-I sites, and there's a cascading effect of genes that then get expressed. And what that seems to do is turn off things like inflammatory markers. It turns on things like CERC-II genes,…”
Feb 10, 2025 positive
Friedberg: Eli Lilly testing GLP-1 drugs for kidney, liver, and mental health conditions
“They have all these Clinical trials going on right now for different indications for the GLP-I receptor agonists that they're seeing that there's health benefits beyond just the weight loss in reducing things like kidney disease, obviously liver problems, ment…”